Molecular Biology of the Cell track citations

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBC in Press, 10.1091/mbc.E05-03-0237 on January 4, 2006

Vol. 17, Issue 3, 1204-1217, March 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
E05-03-0237v1
17/3/1204    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dadke, D.
Right arrow Articles by Golemis, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dadke, D.
Right arrow Articles by Golemis, E. A.

Deregulation of HEF1 Impairs M-Phase Progression by Disrupting the RhoA Activation Cycle

Disha Dadke *, Michael Jarnik, Elena N. Pugacheva, Mahendra K. Singh, and Erica A. Golemis

Division of Basic Science, Fox Chase Cancer Center, Philadelphia, PA 19111

Submitted March 21, 2005; Revised December 18, 2005; Accepted December 28, 2005
Monitoring Editor: Jean Schwarzbauer

The focal adhesion-associated signaling protein HEF1 undergoes a striking relocalization to the spindle at mitosis, but a function for HEF1 in mitotic signaling has not been demonstrated. We here report that overexpression of HEF1 leads to failure of cells to progress through cytokinesis, whereas depletion of HEF1 by small interfering RNA (siRNA) leads to defects earlier in M phase before cleavage furrow formation. These defects can be explained mechanistically by our determination that HEF1 regulates the activation cycle of RhoA. Inactivation of RhoA has long been known to be required for cytokinesis, whereas it has recently been determined that activation of RhoA at the entry to M phase is required for cellular rounding. We find that increased HEF1 sustains RhoA activation, whereas depleted HEF1 by siRNA reduces RhoA activation. Furthermore, we demonstrate that chemical inhibition of RhoA is sufficient to reverse HEF1-dependent cellular arrest at cytokinesis. Finally, we demonstrate that HEF1 associates with the RhoA-GTP exchange factor ECT2, an orthologue of the Drosophila cytokinetic regulator Pebble, providing a direct means for HEF1 control of RhoA. We conclude that HEF1 is a novel component of the cell division control machinery and that HEF1 activity impacts division as well as cell attachment signaling events.


This article was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E05–03–0237) on January 4, 2006.

* Present address: Stem Cell Research Center, Manipal Hospital, Bangalore 560017, India.

Address correspondence to: Erica Golemis (ea_golemis{at}fccc.edu) or Disha Dadke (disha.dadke{at}manipalhospital.org).




This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
M. K. Singh, D. Dadke, E. Nicolas, I. G. Serebriiskii, S. Apostolou, A. Canutescu, B. L. Egleston, and E. A. Golemis
A Novel Cas Family Member, HEPL, Regulates FAK and Cell Spreading
Mol. Biol. Cell, April 1, 2008; 19(4): 1627 - 1636.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. M. O'Neill, S. Seo, I. G. Serebriiskii, S. R. Lessin, and E. A. Golemis
A New Central Scaffold for Metastasis: Parsing HEF1/Cas-L/NEDD9
Cancer Res., October 1, 2007; 67(19): 8975 - 8979.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2006 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.